Evotec’s Oligo Discovery: AI Design & RT-qPCR Screening
Data-Driven Oligonucleotide Discovery in RNAHub
Genedata Selector 2025 Highlights Video
Next-Gen Cell Line Characterization
Valentina Armiento July 23, 2025
Autologous vs. Allogeneic Cell Therapies: Key Insights
Marie-Ange Kouassi July 18, 2025
Automating MS for Faster Oligonucleotide Development
Ada Yee July 17, 2025
Biopharma Data Integration for Smarter Biologics Development
Ada Yee July 16, 2025
Precision Medicine in IMIDs - Path to Improved Healthcare Outcomes
Justyna Lisowska July 14, 2025
Clinical Trial Design Evolution: Key Trends and the Integral Role of Bioinformatics Solutions
Marie-Ange Kouassi July 10, 2025
Industry Experts: Best Practices for Validated Biosafety Workflows
Genedata Selector
Turning Data into Decisions: RAS Inhibitor Case Study
Chemical Liability Screening for Biotherapeutic Protein Discovery
Digitalizing mRNA Workflows for Vaccines and Therapeutics
Enabling MS-Based MAM in QC Through a Robust New Peak Detection Workflow
Merck: X-Omics Platform Accelerates Precision Medicine
Enhancing ROI with Long-Read Sequencing
Raed Hmadi June 16, 2025
NGS-Based Vector Integrity Confirmation for Gene Therapy Products
Genedata June 13, 2025
Journey to Validated NGS In-House
Untargeted HILIC Metabolomics of Soybean Amino Acid Pathways
Robust and Versatile New Peak Detection for MAM Implementation
Boosting Efficiency in High-Throughput Intact Mass Spectrometry
Automated Workflow for Oligonucleotide Mass Mapping
Automated Peptide Mapping for Higher Throughput
Japan: DX Platform for Increasing Success Rates in Pharma R&D
What’s New in Genedata Screener 2025
Integrated Assay Analysis for Antibody Developability
Digital Platform for the Development of Next-Generation ADCs
Automated HT-Engineering Platform for AI-Supported Developability Predictions
Accelerating Biopharmaceutical and Vaccine Research, Discovery, and Development
NGS for CMC of Gene and Cell Therapy Products
Long-Read NGS for QC in CGTs Manufacturing
Validation-Ready NGS Workflows for Biosafety Testing
Accelerating RNA Drug Discovery with Automated Data Analysis
Advanced NGS for CLD in CGT Development
Valentina Armiento April 21, 2025
Do's and Don'ts of CSV for In-House NGS-Based Biosafety Assays
Platform for Streamlined LC/MS-based MAM Implementation
MS Analytics Platform for Emerging Therapeutic Modalities
Scalable, Automated Data Analysis Across RNA Therapeutics Assays
Data in Motion. Accelerated CMC Decisions. Genedata Vico
Data Integration Platform for Bioassays in Preclinical & Clinical Studies
